In vitro activities of natural products against oral Candida isolates from denture wearers

Background: Candida-associated denture stomatitis is a frequent infectious disease. Treatment of this oral condition is difficult because failures and recurrences are common. The aim of this study was to test the in vitro antifungal activity of pure constituents of essentials oils. -- Methods: Eight terpenic derivatives (carvacrol, farnesol, geraniol, linalool, menthol, menthone, terpinen-4-ol, and aterpineol), a phenylpropanoid (eugenol), a phenethyl alcohol (tyrosol) and fluconazole were evaluated against 38 Candida isolated from denture-wearers and 10 collection Candida strains by the CLSI M27-A3 broth microdilution method. -- Results: Almost all the tested compounds showed antifungal activity with MIC ranges of 0.03-0.25% for eugenol and linalool, 0.03-0.12% for geraniol, 0.06-0.5% for menthol, a-terpineol and terpinen-4-ol, 0.03-0.5% for carvacrol, and 0.06-4% for menthone. These compounds, with the exception of farnesol, menthone and tyrosol, showed important in vitro activities against the fluconazole-resistant and susceptible-dose dependent Candida isolates. -- Conclusions: Carvacrol, eugenol, geraniol, linalool and terpinen-4-ol were very active in vitro against oral Candida isolates. Their fungistatic and fungicidal activities might convert them into promising alternatives for the topic treatment of oral candidiasis and denture stomatitis.

Un proyecto de investigación para el desarrollo de la competencia comunicativa oral de los futuros docentes

El V Seminario de "El aula como ámbito de investigación sobre la enseñanza y aprendizaje de la lengua" se celebró en la Universidad del País Vasco (UPV/EHU), dando continuidad a los seminarios ya celebrados en la Universidad Autónoma de Barcelona, en la Universidad de Valencia, en la Universidad de Valladolid y en la Universidad de Braga (Portugal).

Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2

Background: Human melanoma frequently colonizes bone marrow (BM) since its earliest stage of systemic dissemination, prior to clinical metastasis occurrence. However, how melanoma cell adhesion and proliferation mechanisms are regulated within bone marrow stromal cell (BMSC) microenvironment remain unclear. Consistent with the prometastatic role of inflammatory and angiogenic factors, several studies have reported elevated levels of cyclooxygenase-2 (COX-2) in melanoma although its pathogenic role in bone marrow melanoma metastasis is unknown. Methods: Herein we analyzed the effect of cyclooxygenase-2 (COX-2) inhibitor celecoxib in a model of generalized BM dissemination of left cardiac ventricle-injected B16 melanoma (B16M) cells into healthy and bacterial endotoxin lipopolysaccharide (LPS)-pretreated mice to induce inflammation. In addition, B16M and human A375 melanoma (A375M) cells were exposed to conditioned media from basal and LPS-treated primary cultured murine and human BMSCs, and the contribution of COX-2 to the adhesion and proliferation of melanoma cells was also studied. Results: Mice given one single intravenous injection of LPS 6 hour prior to cancer cells significantly increased B16M metastasis in BM compared to untreated mice; however, administration of oral celecoxib reduced BM metastasis incidence and volume in healthy mice, and almost completely abrogated LPS-dependent melanoma metastases. In vitro, untreated and LPS-treated murine and human BMSC-conditioned medium (CM) increased VCAM-1-dependent BMSC adherence and proliferation of B16M and A375M cells, respectively, as compared to basal medium-treated melanoma cells. Addition of celecoxib to both B16M and A375M cells abolished adhesion and proliferation increments induced by BMSC-CM. TNF alpha and VEGF secretion increased in the supernatant of LPS-treated BMSCs; however, anti-VEGF neutralizing antibodies added to B16M and A375M cells prior to LPS-treated BMSC-CM resulted in a complete abrogation of both adhesion-and proliferation-stimulating effect of BMSC on melanoma cells. Conversely, recombinant VEGF increased adherence to BMSC and proliferation of both B16M and A375M cells, compared to basal medium-treated cells, while addition of celecoxib neutralized VEGF effects on melanoma. Recombinant TNFa induced B16M production of VEGF via COX-2-dependent mechanism. Moreover, exogenous PGE2 also increased B16M cell adhesion to immobilized recombinant VCAM-1. Conclusions: We demonstrate the contribution of VEGF-induced tumor COX-2 to the regulation of adhesion-and proliferation-stimulating effects of TNFa, from endotoxin-activated bone marrow stromal cells, on VLA-4-expressing

Análisis histológico e inmunohistoquímico de los subtipos de enfermedad liquenoide oral

176 p. : il.

Efectividad del método canguro en el tratamiento del dolor en neonatos prematuros y de bajo peso gestacional junto a sacarosa oral en la técnica punción del talón en la Unidad Neonatal.

Durante muchos años se consideró que los neonatos no experimentaban el dolor por su incapacidad para verbalizarlo. Así, concepciones erróneas hicieron que el dolor neonatal no fuese tratado. En la actualidad, existe evidencia científica que corrobora la capacidad para percibir el dolor, siendo necesario su tratamiento. Aun así, el miedo a los posibles efectos secundarios de los fármacos ha obstaculizado el estudio de nuevos fármacos para el tratamiento del dolor. Es por eso que las estrategias no farmacológicas han tomado gran relevancia en el tratamiento de procedimientos dolorosos menores, y como coadyuvantes de los fármacos en procedimientos de mayor intensidad. El método canguro que se define como un contacto piel a piel entre madre e hijo, surgió como una alternativa ante la escasez de incubadoras. Sin embargo, numerosas investigaciones han demostrado los grandes beneficios que aporta, considerándolo también como una medida no farmacológica eficaz en el alivio del dolor neonatal. El objetivo de este estudio es evaluar la efectividad del método canguro junto a la administración de sacarosa oral en la disminución del dolor, en comparación con el procedimiento estándar al realizar la prueba de talón. Para ello, se realizará un ensayo clínico aleatorizado dirigido a los neonatos prematuros y de bajo peso gestacional ingresados en la unidad de neonatal del Hospital universitario de Cruces. La variable principal a estudio es la valoración del dolor medido mediante la escala PIPP. Se compararán los datos recogidos en el grupo control e intervención y el análisis de datos se realizará usando el programa informático SPSS.

Morphofunctional changes in a rat model of Parkinson's disease - Effects of neurotrophic factors administration

255 p.

Efecto de la suplementación oral con monohidrato de creatina en la capacidad de sprint en jugadores de fútbol sala

Propósito: Esta investigación examina los efectos de la suplementación con creatina en los esfuerzos de alta intensidad no prolongados en el tiempo, más concretamente en la posible mejora de la capacidad de sprint en jugadores de fútbol sala. Método: el estudio está diseñado con formato doble ciego. Se ha realizado a 10 jugadores varones integrantes de un equipo de fútbol sala, unas mediciones antropométricas (masa total y estatura) y unas pruebas que miden su rendimiento, estrechamente relacionadas con la capacidad de “sprint” (Squat Jump, Counter Movement Jump y Sprint de 20 metros de distancia lanzado).Después de esta primera recogida de datos, los jugadores han sido incluidos en un grupo que ha sido suplementado con CREATINA, o en un grupo PLACEBO. Ambos grupos tomaron durante 6 días, 20 gramos de producto, y una vez finalizado este periodo, se repitieron de nuevo tanto las mediciones antropométricas, como las pruebas de rendimiento. Concluidas estas segundas mediciones, comenzaron a tomar únicamente 5 gramos diarios durante 28 días, y de nuevo, una vez acabado este periodo, se repitieron las pruebas y mediciones. Resultados: No ha habido diferencias significativas que muestren cambios del IMC en ninguno de los dos grupos. Si existen mejoras significativas en las pruebas de rendimiento de las segundas mediciones respecto a las primeras, pero no son achacables a la ingesta de monohidrato de creatina, ya que sujetos de ambos grupos han mejorado. Conclusión: la creatina no ha mejorado la capacidad de sprint de estos deportistas. IDIOMA: ESPAÑOL.

FTY720 attenuates excitotoxicity and neuroinflammation

Background: FTY720 (fingolimod, Gilenya(TM)), a structural analog of sphingosine-1-phosphate (S1P), is the first oral drug approved for treatment the relapsing-remitting form of multiple sclerosis (MS), and its efficacy has been related to induced lymphopenia and consequent immunosuppression via modulation of S1P(1) receptors (S1P(1)R). However, due to its lipophilic nature, FTY720 crosses the blood brain barrier (BBB) and could act directly on neural cells. In this study, we investigated the effectiveness of FTY720 as a neuroprotective agent using in vitro and in vivo models of excitotoxic neuronal death and examined if FTY720 exerts a direct action on neurons, or/and an indirect modulation of inflammation-mediated neurodegeneration as a possible mechanism of neuroprotection. Methods: Primary neuronal and organotypic cortical cultures were treated with N-methyl-D-aspartic acid (NMDA) to induce excitotoxic cell death (measured by lactate dehydrogenase (LDH) assay or propidium iodide uptake, respectively). The effects of FTY720 treatment (10, 100 and 1,000 nM) on neuronal survival were examined. As an in vivo model of neuronal death and inflammation, we used intracerebroventricular (icv) administration of kainic acid (KA; 0.5 mu g/2 mu l) in Sprague-Dawley rats. FTY720 was applied icv (1 mu g/2 mu l), together with KA, plus intraperitoneally (ip; 1 mg/kg) 24 h before, and daily, until sacrifice 3 days after icv. Rats were evaluated for neurological score, neuronal loss in CA3 hippocampal region and activation of microglia at the lesion site. In addition, we tested FTY720 as a modulator of microglia responses using microglial cell cultures activated with lipopolysaccharide (LPS) and its effects in stress signalling pathways using western blotting for p38 and JNK1/2 mitogen-activated protein kinases (MAPKs). Results: FTY720 was able to reduce excitotoxic neuronal death in vitro. Moreover, in vivo repeated FTY720 administration attenuated KA-induced neurodegeneration and microgliosis at the CA3 lesion site. Furthermore, FTY720 negatively modulates p38 MAPK in LPS-activated microglia, whereas it had no effect on JNK1/2 activation. Conclusions: These data support a role for FTY720 as a neuroprotective agent against excitotoxin-induced neuronal death and as a negative modulator of neuroinflammation by targeting the p38 MAPK stress signalling pathway in microglia.

El perfil criminológico en las fases de investigación y juicio oral. Un estudio de caso filicidio

Posibilidades de ayuda del perfil criminológico en el descubrimiento, identificación y captura del delincuente en el ámbito policial y forense judicial. Realización de un perfil criminológico acerca de un caso enjuiciado en la Audiencia Provincial de Gipuzkoa.

Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease

Current research efforts are focused on the application of growth factors, such as glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), as neuroregenerative approaches that will prevent the neurodegenerative process in Parkinson's disease. Continuing a previous work published by our research group, and with the aim to overcome different limitations related to growth factor administration, VEGF and GDNF were encapsulated in poly(lactic-co-glycolic acid) nanospheres (NS). This strategy facilitates the combined administration of the VEGF and GDNF into the brain of 6-hydroxydopamine (6-OHDA) partially lesioned rats, resulting in a continuous and simultaneous drug release. The NS particle size was about 200 nm and the simultaneous addition of VEGF NS and GDNF NS resulted in significant protection of the PC-12 cell line against 6-OHDA in vitro. Once the poly(lactic-co-glycolic acid) NS were implanted into the striatum of 6-OHDA partially lesioned rats, the amphetamine rotation behavior test was carried out over 10 weeks, in order to check for in vivo efficacy. The results showed that VEGF NS and GDNF NS significantly decreased the number of amphetamine-induced rotations at the end of the study. In addition, tyrosine hydroxylase immunohistochemical analysis in the striatum and the external substantia nigra confirmed a significant enhancement of neurons in the VEGF NS and GDNF NS treatment group. The synergistic effect of VEGF NS and GDNF NS allows for a reduction of the dose by half, and may be a valuable neurogenerative/neuroreparative approach for treating Parkinson's disease.

Aproximación al lenguaje femenino en la prensa escrita (revistas del corazón) y en el registro oral

Inmersión en el uso femenino del lenguaje a través del análisis de diversos artículos (bibliográficos, periodísticos), documentos y encuestas.